JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
iShares MSCI World ETF
URTH
$8.36B
| $95.5M | 0.02% |
1,083,339
+582
| +0.1% | +$50.3K |
|
677
Sysco
SYY
$40.3B
| $95.3M | 0.02% |
1,568,888
-858,213
| -35% | -$48.6M |
|
|
ESRX
678
DELISTED
Express Scripts Holding Company
ESRX
| $95.1M | 0.02% |
1,273,964
+408,655
| +47% | +$26.1M |
|
|
CONE
679
DELISTED
CyrusOne Inc Common Stock
CONE
| $95.1M | 0.02% |
1,597,246
+75,315
| +5% | +$4.57M |
|
680
MillerKnoll
MLKN
$1.67B
| $94.9M | 0.02% |
2,368,528
+138,801
| +6% | +$4.87M |
|
681
Globant
GLOB
$1.61B
| $94.3M | 0.02% |
2,028,954
-281,382
| -12% | -$11.3M |
|
|
DEA
682
Easterly Government Properties
DEA
$1.18B
| $94.1M | 0.02% |
1,764,046
-340,467
| -16% | -$17.8M |
|
683
The Mosaic Company
MOS
$7.33B
| $93.9M | 0.02% |
3,659,517
-2,104,959
| -37% | -$48.4M |
|
|
PPLN
684
DELISTED
Cushing 30 MLP Index ETNs due June 15, 2037
PPLN
| $93.8M | 0.02% |
4,700,000
-25,000
| -0.5% | -$492K |
|
685
AGCO
AGCO
$7.2B
| $93.4M | 0.02% |
1,307,899
+557,894
| +74% | +$39.8M |
|
686
Affiliated Managers Group
AMG
$9.76B
| $93.4M | 0.02% |
455,066
-138,235
| -23% | -$26.8M |
|
687
Canadian National Railway
CNI
$76.6B
| $93.1M | 0.02% |
1,128,690
-142,182
| -11% | -$11.5M |
|
688
Manhattan Associates
MANH
$11.4B
| $93M | 0.02% |
1,877,009
+35,812
| +2% | +$1.61M |
|
689
Blackbaud
BLKB
$2.08B
| $92.9M | 0.02% |
983,140
+37,295
| +4% | +$3.59M |
|
690
Oneok
OKE
$54.5B
| $92.9M | 0.02% |
1,737,191
+785,027
| +82% | +$41.9M |
|
|
HF
691
DELISTED
HFF Inc.
HF
| $92.8M | 0.02% |
1,907,807
-83,651
| -4% | -$3.69M |
|
692
United Therapeutics
UTHR
$23.1B
| $92.6M | 0.02% |
625,705
-14,770
| -2% | -$1.88M |
|
693
Emerson Electric
EMR
$88.3B
| $92.5M | 0.02% |
1,327,263
-432,246
| -25% | -$28M |
|
|
CPN
694
DELISTED
Calpine Corporation
CPN
| $92.5M | 0.02% |
6,112,144
-2,106,843
| -26% | -$31.6M |
|
695
Royal Bank of Canada
RY
$293B
| $92.4M | 0.02% |
1,131,156
-224,863
| -17% | -$17.8M |
|
|
AABA
696
CALL
DELISTED
Altaba Inc
AABA
| $92.3M | 0.02% |
1,321,900
+693,900
| +110% | +$48.3M |
|
697
Vistra
VST
$47.4B
| $92.1M | 0.02% |
5,027,868
+355,636
| +8% | +$6.66M |
|
|
CLGX
698
DELISTED
Corelogic, Inc.
CLGX
| $92.1M | 0.02% |
1,992,827
+31,823
| +2% | +$1.47M |
|
699
Evolent Health
EVH
$447M
| $91.9M | 0.02% |
7,470,074
+5,055
| +0.1% | +$71.3K |
|
700
Dollar General
DG
$27.9B
| $91.8M | 0.02% |
987,180
-674,504
| -41% | -$58M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.